Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: partial overlay denture
Total 0 results
Nothing found
Sponsors and Collaborators
Ministère de la Santé et l'Hygiène Publique, Mali
STAG1 Gene Foundation
Yu-Hsiang Wu
E. Steve Woodle
MITO
BiondVax Pharmaceuticals ltd.
Department of Emergency Medicine, The First People's Hospital of Hangzhou, Hangzhou, China.
OLVG, Amsterdam, the Netherlands
Nottingham University Hospitals NHS Trust
Bruno Rhiner
AtheroNova Inc.
Camilla Wistrand
Medical College Trivandrum
Virginia G. Kaklamani
LM Farma Indústria e Comércio Ltda.
GenVivo, Inc.
Vituity Psychiatry
Eyal Ashkenazi
Asahi Kasei Medical Co., Ltd.
Katarzyna Jórasz
View Full List
Medical Conditions
Stage IVA Lymphoepithelioma of the Oropharynx
Autism or Autistic Traits
HPV-Related Anal Intraepithelial Neoplasia
Phenoxymethylpenicillin
Nondepolarising Muscle Relaxants
NR3C2
Cervical Cancer Stage IA2
Any Injury or Illness Acutely Impacting Work
Rotator Cuff Lesion
Mast-Cell Sarcoma
Patients Who Had the Urine Volume at Nighttime More Than One Third of Total Daily Urine Volume (NPU) and Voided More Than Two Times at Nighttime (Nocturia)
Symptoms
Child Physical Activity
Learning Disturbance
Imaging, Diagnostic
Synbiotics
Soft Tissue Sarcoma, Adult, Stage II
Alpha-Dystroglycanopathy (Dystroglycanopathy, Congenital With or Without Mental Retardation (Formerly MDC1C))
Serum Bank
Intensive Care Neuropathy
View Full List
Drug Interventions
Dexmedetomidine
Lidocaine/ ketamine
Camrelizumab for injection (200 mg, iv), D1, Q2W, 14-day cycle
Interferon beta-1b (Betaferon, BAY86-5046)
Transdermal estradiol
5-Fluorouracil
Rituximab plus CHOP
Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA]
Interleukin-2
Miglustat
CD25 treatment
Insulin
LDEPA
Apremilast
Exendin 9-39
FHND5071
Thiotepa
Methotrexate
Extended release guanfacine
Ozanimod
View Full List
CROs by country
Contract Research Organizations in Bangladesh
Contract Research Organizations in Colombia
Contract Research Organizations in Costa Rica
Contract Research Organizations in El Salvador
Contract Research Organizations in Ghana
Contract Research Organizations in Italy
Contract Research Organizations in Kenya
Contract Research Organizations in Pakistan
Contract Research Organizations in Romania
Contract Research Organizations in Saudi Arabia
Contract Research Organizations in Sweden
Contract Research Organizations in Switzerland
Contract Research Organizations in Uruguay
CRO list by country
CROs in Malta
SGS
All CROs in Malta
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe